These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35371270)

  • 101. Current and future therapies for treating chronic spontaneous urticaria.
    Maurer M; Vena GA; Cassano N; Zuberbier T
    Expert Opin Pharmacother; 2016 Jun; 17(8):1131-9. PubMed ID: 26918673
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Primary Non-Adherence to Antihistamines-Conclusions From E-Prescription Pilot Data in Poland.
    Kardas G; Panek M; Kuna P; Cieszyński J; Kardas P
    Front Pharmacol; 2020; 11():783. PubMed ID: 32528297
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Exploring the safety profile of bilastine in chronic spontaneous urticaria: A real-world analysis in the Indian population.
    Kumaran MS; Mehta H; Hemalatha M; Parsad D
    Indian J Dermatol Venereol Leprol; 2024 Jul; ():1-3. PubMed ID: 39152847
    [No Abstract]   [Full Text] [Related]  

  • 104. Prevalence and potential risk factors of urticaria in the Polish population of children and adolescents.
    Mazur M; Czarnobilska M; Czarnobilska E
    Postepy Dermatol Alergol; 2020 Oct; 37(5):785-789. PubMed ID: 33240021
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Bilastine for allergic rhinoconjunctivitis, urticaria.
    Aust Prescr; 2022 Oct; 45(5):179. PubMed ID: 36382168
    [No Abstract]   [Full Text] [Related]  

  • 106. Real-World Clinical Experience with Oral Cyclosporine in Antihistamine Refractory Cases of Chronic Spontaneous Urticaria.
    Sehgal S; Agarwal S; Balai M; Meghwal L; Mittal A
    Indian Dermatol Online J; 2024; 15(5):887-890. PubMed ID: 39359277
    [No Abstract]   [Full Text] [Related]  

  • 107. Comparison of the Efficacy and Safety of Bilastine 20 mg versus Fexofenadine 180 mg for Treatment of Perennial Allergic Rhinitis: Randomized Controlled Study.
    Singhal A; Agrawal P; Chatterji P; Matreja PS; Mahmood T
    Indian J Otolaryngol Head Neck Surg; 2024 Oct; 76(5):4025-4030. PubMed ID: 39376275
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Efficacy and safety of switching to bilastine, an H1-antihistamine, in patients with refractory chronic spontaneous urticaria (H1-SWITCH): a multicenter, open-label, randomized, parallel-group comparative study.
    Fukunaga A; Kakei Y; Murakami S; Kan Y; Masuda K; Jinnin M; Washio K; Amano H; Nagano T; Yamamoto A; Otsuka T; Takahagi S; Takenaka M; Ishiguro N; Hayama K; Inomata N; Nakagawa Y; Sugiyama A; Hide M
    Front Immunol; 2024; 15():1441478. PubMed ID: 39351222
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Bilastine in Refractory Chronic Spontaneous Urticaria: Disease Control and Cytokine Modulation in an Open-label Prospective Study.
    De A; Singh S; Chakraborty D; Sarda A; Godse K
    Indian J Dermatol; 2024; 69(2):132-136. PubMed ID: 38841225
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Experience with bilastine in the management of urticaria: Original Real-world cases of Bilastine In Treatment (ORBIT) in Asia.
    Cheong WK; Chan AWM; Ch'ng CC; Chung WH; Gabriel MT; Godse K; Mitthamsiri W; Nguyen HT; Tiongco-Recto M; Nagrale D
    Drugs Context; 2022; 11():. PubMed ID: 35371270
    [TBL] [Abstract][Full Text] [Related]  

  • 111. One-year safety and efficacy study of bilastine treatment in Japanese patients with chronic spontaneous urticaria or pruritus associated with skin diseases.
    Yagami A; Furue M; Togawa M; Saito A; Hide M
    J Dermatol; 2017 Apr; 44(4):375-385. PubMed ID: 27862227
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Role of bilastine in the management of allergic rhinitis and urticaria: an Asia-Pacific consensus statement.
    Mösges R; Lee DL; Abong J; Siasoco B; Chow SK; Leong JL; Singh H; Kuljit S; Campomanes B
    Asia Pac Allergy; 2016 Jan; 6(1):56-66. PubMed ID: 26844221
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Pharmacokinetics and safety of bilastine in children aged 6 to 11 years with allergic rhinoconjunctivitis or chronic urticaria.
    Rodríguez M; Vozmediano V; García-Bea A; Novák Z; Yáñez A; Campo C; Labeaga L
    Eur J Pediatr; 2020 May; 179(5):801-805. PubMed ID: 31919579
    [TBL] [Abstract][Full Text] [Related]  

  • 114. How bilastine is used to treat allergic rhinitis and urticaria in children.
    Rodríguez Del Río P; Rodríguez Fernández F; Ballester Asensio E; Tortajada-Girbés M
    Immunotherapy; 2022 Jan; 14(1):77-89. PubMed ID: 34850647
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Bilastine 10 and 20 mg in paediatric and adult patients: an updated practical approach to treatment decisions.
    Leceta A; García A; Sologuren A; Campo C
    Drugs Context; 2021; 10():. PubMed ID: 34457015
    [TBL] [Abstract][Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.